|
|
 |
|
|
|
|
| Your Result on : Balance Sheet |
|
|
|
|
| Procter & Gamble Health Ltd |
Industry : Pharmaceuticals - Multinational |
|
|
|
|
|
| Book Value (Rs) |
|
| 373.3448522 |
|
|
|
|
|
|
Market Cap
(Rs In Cr.) |
|
| 8,729 |
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
High (Rs) |
Low (Rs) |
Close (Rs) |
P/E High |
P/E Low |
P/E Close |
Mkt Cap.
(Rs In Cr.) |
| Jan 2026 |
5,901.00 |
5,295.05 |
5,300.10 |
42.85 |
37.44 |
37.52 |
8,797.84 |
| Share Prices Of
2025
|
| Dec 2025 |
5,899.95 |
5,531.55 |
5,701.10 |
43.74 |
38.43 |
40.35 |
9,463.47 |
| Nov 2025 |
6,164.00 |
5,700.00 |
5,729.00 |
44.91 |
39.61 |
40.55 |
9,509.79 |
| Oct 2025 |
6,386.00 |
6,001.15 |
6,174.35 |
45.98 |
42.13 |
43.70 |
10,249.04 |
| Sep 2025 |
6,558.60 |
6,200.05 |
6,311.05 |
47.08 |
43.29 |
44.67 |
10,475.95 |
| Aug 2025 |
6,700.00 |
5,901.00 |
6,363.75 |
49.93 |
39.76 |
45.04 |
10,563.43 |
| Jul 2025 |
6,100.00 |
5,600.15 |
5,899.55 |
44.27 |
37.63 |
41.76 |
9,792.89 |
| Jun 2025 |
6,107.55 |
5,534.60 |
5,878.85 |
45.22 |
39.06 |
41.61 |
9,758.53 |
| May 2025 |
5,939.80 |
4,955.35 |
5,775.85 |
43.24 |
34.55 |
40.88 |
9,587.55 |
| Apr 2025 |
5,333.80 |
4,965.35 |
5,072.65 |
38.03 |
33.94 |
35.91 |
8,420.29 |
| Mar 2025 |
5,582.70 |
4,916.00 |
5,142.30 |
40.32 |
34.23 |
36.40 |
8,535.90 |
| Feb 2025 |
5,679.95 |
4,916.50 |
4,991.70 |
46.28 |
37.27 |
38.42 |
8,285.91 |
| Jan 2025 |
5,575.00 |
4,979.80 |
5,384.65 |
43.51 |
36.38 |
41.44 |
8,938.19 |
| Share Prices Of
2024
|
| Dec 2024 |
5,774.80 |
5,101.00 |
5,237.80 |
45.19 |
39.13 |
40.31 |
8,694.42 |
| Nov 2024 |
5,835.95 |
5,052.35 |
5,189.95 |
45.39 |
38.39 |
39.94 |
8,615.00 |
| Oct 2024 |
5,549.60 |
4,912.30 |
5,234.25 |
42.84 |
37.21 |
40.28 |
8,688.53 |
| Sep 2024 |
5,560.00 |
5,044.95 |
5,428.60 |
43.10 |
38.42 |
41.78 |
9,011.14 |
| Aug 2024 |
5,489.55 |
5,000.00 |
5,196.65 |
42.77 |
37.26 |
39.99 |
8,626.12 |
| Jul 2024 |
5,407.30 |
4,989.45 |
5,254.10 |
43.05 |
37.49 |
40.44 |
8,721.48 |
| Jun 2024 |
5,099.25 |
4,649.50 |
5,049.85 |
39.63 |
34.62 |
38.86 |
8,382.44 |
|
| PREV |
NEXT
|
|
|
|
|
|
|
|
|
|